PASADENA, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- OmniPathology today announced the launch of its COVID-19 Lab Developed Test LDT. In response to the US Food and Drug Administration (FDA) policy announcement on February 29, 2020, seeking high complexity laboratories to start developing diagnostic tests for Coronavirus to address the COVID-19 outbreak. Recognizing the urgent need for a new COVID-19 test, OmniPathology reallocated all its research and development resources to develop the new test.?
Copyright © 2021 Biotech Networks, LLC
